Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew B Schabath

Showing results (91-100 of 246) with videos related to

Pageof 25
Sort By:
Plos One|August 11, 2016
Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening TrialMatthew B Schabath, Pierre P Massion, Zachary J Thompson, et al.
Cancer Biomarkers : Section a of Disease Markers|May 2, 2022
Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancersJaileene Pérez-Morales, Hong Lu, Wei Mu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 30, 2019
Multi-window CT based Radiomic signatures in differentiating indolent versus aggressive lung cancers in the National Lung Screening Trial: a retrospective studyHong Lu, Wei Mu, Yoganand Balagurunathan, et al.
Journal of Gay & Lesbian Social Services|April 19, 2019
Lesbian, Gay, Bisexual, Transgender, Queer/Questioning (LGBTQ) Perceptions and Health Care ExperiencesGwendolyn P Quinn, Steven K Sutton, Brian Winfield, et al.
Nature Reviews. Urology|January 18, 2024
A clinical overview of people living with HIV and genitourinary cancer careChalairat Suk-Ouichai, Anna E Coghill, Matthew B Schabath, et al.
Cancer Research|December 21, 2006
Matrix metalloproteinase polymorphisms and bladder cancer riskA Karim Kader, Lina Shao, Colin P Dinney, et al.
JNCI Cancer Spectrum|March 20, 2025
Easy ensemble classifier-group and intersectional fairness and threshold (EEC-GIFT): a fairness-aware machine learning framework for lung cancer screening eligibility using real-world dataPiyawan Conahan, Lary A Robinson, Trung Le, et al.
JNCI Cancer Spectrum|September 22, 2023
Overview of approaches to estimate real-world disease progression in lung cancerRossybelle Amorrortu, Melany Garcia, Yayi Zhao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men StudyVictoria Umutoni, Matthew B Schabath, Alan G Nyitray, et al.
Proteomics. Clinical Applications|February 14, 2015
Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicineElisa Baldelli, Eric B Haura, Lucio Crinò, et al.
Pageof 25

Showing results (91-100 of 246) with videos related to

Sort By:
Pageof 25
Plos One|August 11, 2016
Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening TrialMatthew B Schabath, Pierre P Massion, Zachary J Thompson, et al.
Cancer Biomarkers : Section a of Disease Markers|May 2, 2022
Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancersJaileene Pérez-Morales, Hong Lu, Wei Mu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 30, 2019
Multi-window CT based Radiomic signatures in differentiating indolent versus aggressive lung cancers in the National Lung Screening Trial: a retrospective studyHong Lu, Wei Mu, Yoganand Balagurunathan, et al.
Journal of Gay & Lesbian Social Services|April 19, 2019
Lesbian, Gay, Bisexual, Transgender, Queer/Questioning (LGBTQ) Perceptions and Health Care ExperiencesGwendolyn P Quinn, Steven K Sutton, Brian Winfield, et al.
Nature Reviews. Urology|January 18, 2024
A clinical overview of people living with HIV and genitourinary cancer careChalairat Suk-Ouichai, Anna E Coghill, Matthew B Schabath, et al.
Cancer Research|December 21, 2006
Matrix metalloproteinase polymorphisms and bladder cancer riskA Karim Kader, Lina Shao, Colin P Dinney, et al.
JNCI Cancer Spectrum|March 20, 2025
Easy ensemble classifier-group and intersectional fairness and threshold (EEC-GIFT): a fairness-aware machine learning framework for lung cancer screening eligibility using real-world dataPiyawan Conahan, Lary A Robinson, Trung Le, et al.
JNCI Cancer Spectrum|September 22, 2023
Overview of approaches to estimate real-world disease progression in lung cancerRossybelle Amorrortu, Melany Garcia, Yayi Zhao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men StudyVictoria Umutoni, Matthew B Schabath, Alan G Nyitray, et al.
Proteomics. Clinical Applications|February 14, 2015
Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicineElisa Baldelli, Eric B Haura, Lucio Crinò, et al.
Pageof 25